Sir Charles Gairdner Hospital, Perth, Australia.
Department of Anatomical Pathology, PathWest Laboratory Medicine, Perth, Australia.
Am J Dermatopathol. 2024 Sep 1;46(9):601-604. doi: 10.1097/DAD.0000000000002793. Epub 2024 Jul 12.
Refractory celiac disease (RCD) is a rare condition characterized by persistent malabsorptive symptoms and villous atrophy despite a gluten-free diet. While RCD type 1 has a normal intraepithelial lymphocyte phenotype, RCD type 2 is defined by the presence of immunophenotypically aberrant and monoclonal intraepithelial T lymphocytes, with a high propensity to transform to enteropathy-associated T-cell lymphoma (EATL). Although dermatological manifestations of celiac disease are common, presentation with cutaneous involvement by abnormal lymphocytes of RCD type 2 or EATL is rare, with few histologic descriptions in the literature. We describe the case of a 66-year-old man with a history of celiac disease presenting with a generalized, erythematous papular rash over his torso, upper arms, and legs. Biopsy of his skin lesions showed prominent hyperkeratosis with underlying spongiosis and interface change. Increased intraepithelial (epidermotropic) lymphocytes were observed, out of proportion to the level of spongiosis, but not overly atypical in appearance. Immunohistochemistry revealed an aberrant T-cell immunophenotype (CD3/2/7 positive; CD5/4/8 negative), raising suspicion for a cutaneous T-cell lymphoproliferative disorder. A duodenal biopsy demonstrated total villous atrophy with a morphologically bland population of epitheliotropic T lymphocytes showing the same aberrant immunophenotype. Similar cells were also identified by flow cytometry in the peripheral blood. In conjunction with the history of celiac disease, a diagnosis of RCD type 2 or 'EATL in situ' with cutaneous involvement was made. Cutaneous RCD type 2 or EATL should be considered as differential diagnoses in patients with a history of celiac disease and histopathology reminiscent of epidermotropic forms of cutaneous T-cell lymphoma.
难治性乳糜泻(RCD)是一种罕见的疾病,其特征是尽管采用了无麸质饮食,但仍存在持续性吸收不良症状和绒毛萎缩。虽然 RCD 1 型具有正常的上皮内淋巴细胞表型,但 RCD 2 型的定义是存在免疫表型异常和单克隆上皮内 T 淋巴细胞,并且向肠病相关 T 细胞淋巴瘤(EATL)转化的倾向较高。尽管乳糜泻的皮肤表现很常见,但 RCD 2 型或 EATL 异常淋巴细胞累及皮肤的表现很少见,文献中仅有少数组织学描述。我们描述了一例 66 岁男性,患有乳糜泻病史,表现为躯干、上臂和腿部广泛的红斑性丘疹性皮疹。皮肤病变活检显示明显的角化过度,伴有底层海绵形成和界面改变。观察到上皮内(表皮内)淋巴细胞增多,与海绵形成不成比例,但外观不太异常。免疫组化显示异常 T 细胞免疫表型(CD3/2/7 阳性;CD5/4/8 阴性),提示存在皮肤 T 细胞淋巴增生性疾病。十二指肠活检显示全部绒毛萎缩,伴有形态上良性的上皮内 T 淋巴细胞,表现出相同的异常免疫表型。在外周血中也通过流式细胞术鉴定出类似的细胞。结合乳糜泻病史,诊断为 RCD 2 型或“原位”EATL 伴皮肤累及。对于有乳糜泻病史和组织病理学类似于皮肤 T 细胞淋巴瘤表皮内形式的患者,应考虑 RCD 2 型或 EATL 作为鉴别诊断。